We are live on
!
Find out more
LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Est. Return
10.14%
This Fund
S&P 500
This Quarter
Est. Return
+7.65%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$939M
AUM Growth
+$86.2M
(+10%)
Cap. Flow
+$29.6M
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
46.18%
Holding
2,925
New
150
Increased
988
Reduced
857
Closed
215
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Stock ETF
VXUS
|
+$5.37M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7M |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$2.54M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$2.12M |
| 5 |
NVIDIA
NVDA
|
+$1.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$6.88M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$4.62M |
| 3 |
Oaktree Specialty Lending
OCSL
|
+$825K |
| 4 |
MGI
MoneyGram International, Inc. New
MGI
|
+$627K |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$562K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.18% |
| 2 | Technology | 15.3% |
| 3 | Healthcare | 6.27% |
| 4 | Consumer Discretionary | 3.61% |
| 5 | Industrials | 3.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Envista
NVST
$4.52B
| $2.13K | ﹤0.01% |
63
-44
| -41% | -$1.55K |
|
2127
GlobalFoundries
GFS
$29.6B
| $2.13K | ﹤0.01% |
33
-26
| -44% | -$1.57K |
|
2128
BRC Group Holdings
RILY
$289M
| $2.12K | ﹤0.01% |
+46
| New | +$1.62K |
|
2129
Methode Electronics
MEI
$592M
| $2.11K | ﹤0.01% |
63
| – | – |
|
|
NOAH
2130
Noah Holdings
NOAH
$603M
| $2.11K | ﹤0.01% |
150
-481
| -76% | -$7.52K |
|
2131
Huntsman Corp
HUN
$1.77B
| $2.11K | ﹤0.01% |
78
+45
| +136% | +$1.17K |
|
2132
M/I Homes
MHO
$3.84B
| $2.09K | ﹤0.01% |
24
+9
| +60% | +$637 |
|
2133
Navient
NAVI
$853M
| $2.08K | ﹤0.01% |
112
+37
| +49% | +$608 |
|
2134
Alector
ALEC
$199M
| $2.08K | ﹤0.01% |
+346
| New | +$2.42K |
|
2135
Certara
CERT
$1.25B
| $2.08K | ﹤0.01% |
114
| – | – |
|
2136
Ocular Therapeutix
OCUL
$2.02B
| $2.07K | ﹤0.01% |
401
| – | – |
|
2137
Alta Equipment Group
ALTG
$245M
| $2.06K | ﹤0.01% |
119
| – | – |
|
|
REVG
2138
DELISTED
REV Group
REVG
| $2.06K | ﹤0.01% |
155
-270
| -64% | -$3.08K |
|
2139
National Presto Industries
NPK
$989M
| $2.05K | ﹤0.01% |
28
-63
| -69% | -$4.63K |
|
2140
Dycom Industries
DY
$12.3B
| $2.05K | ﹤0.01% |
18
| – | – |
|
2141
SEI Investments
SEIC
$12.6B
| $2.03K | ﹤0.01% |
34
| – | – |
|
2142
First Bancorp
FBP
$4.38B
| $2K | ﹤0.01% |
164
| – | – |
|
|
CHS
2143
DELISTED
Chicos FAS, Inc.
CHS
| $2K | ﹤0.01% |
373
| – | – |
|
2144
Fidelity High Dividend ETF
FDVV
$10.5B
| $1.99K | ﹤0.01% |
50
| – | – |
|
2145
Andersons Inc
ANDE
$2.22B
| $1.98K | ﹤0.01% |
43
| – | – |
|
2146
OFG Bancorp
OFG
$2.21B
| $1.98K | ﹤0.01% |
76
| – | – |
|
2147
Rackspace Technology
RXT
$1.24B
| $1.98K | ﹤0.01% |
728
-2,603
| -78% | -$4.29K |
|
|
BASE
2148
DELISTED
Couchbase
BASE
| $1.98K | ﹤0.01% |
125
| – | – |
|
|
ONTF
2149
DELISTED
ON24
ONTF
| $1.97K | ﹤0.01% |
243
-1,117
| -82% | -$9.28K |
|
2150
Cable One
CABO
$212M
| $1.97K | ﹤0.01% |
3
-29
| -91% | -$19.6K |
|
Similar funds
SBIA
CHP
MW
TAM
SIA
CIG
CCM
WCF
Lindbrook Capital's Q2 2023 Portfolio in Review
As of Q2 2023, Lindbrook Capital held 2,925 positions worth $939M, up 10% from $853M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Lindbrook Capital deployed $29.6M of net new capital in Q2 2023, opening 150 new positions and adding to 988 existing holdings. Its largest new stake was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $6.88M trimmed.
- Lindbrook Capital's largest Q2 2023 buy was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
- Lindbrook Capital added most to Vanguard Total International Stock ETF in Q2 2023, an estimated $5.37M increase.
- Lindbrook Capital's biggest Q2 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $6.88M.
- Lindbrook Capital fully exited MoneyGram International, Inc. New in Q2 2023, selling an estimated $627K.
- Lindbrook Capital's ten largest holdings make up 46% of its $939M portfolio in Q2 2023.
- Lindbrook Capital opened 150 new positions and closed 215 in Q2 2023.
- Lindbrook Capital's portfolio value rose 10% quarter-over-quarter to $939M.
Based on Lindbrook Capital's 13F filing for Q2 2023, filed 31 Jul 2023.